
Opinion|Videos|November 8, 2024
Impact of Treatment Delays on Patient Outcomes
Author(s)Toby Maher, MD, PhD
Key Takeaways
- Timely intervention in oncology is critical for improving survival rates, disease progression, and quality of life.
- Delays in treatment can result in advanced disease stages, reduced treatment efficacy, and increased morbidity.
Toby Maher, MD, PhD, discusses how delays in treatment for idiopathic pulmonary fibrosis (IPF) can significantly worsen patient outcomes and accelerate disease progression, underscoring the critical need for timely intervention.
Advertisement
Episodes in this series

Video content above is prompted by the following:
How does a delay in treatment affect patient outcomes and disease progression?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Special Report: The Oncology Care Model, 10 Years Later
2
Patients on GLP-1s Increasingly Carry Diagnoses for New Indications
3
Targeting Oxidative Stress Could Fill a Gap in the Vitiligo Treatment Toolbox
4
How Hospital Specialty Pharmacies Are Closing the Pharmacy Desert Gap
5







